An overview on microglial origin, distribution, and phenotype in Alzheimer's disease

J Cell Physiol. 2022 Jul 13:10.1002/jcp.30829. doi: 10.1002/jcp.30829. Online ahead of print.

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease that is responsible for about one-third of dementia cases worldwide. It is believed that AD is initiated with the deposition of Ab plaques in the brain. Genetic studies have shown that a high number of AD risk genes are expressed by microglia, the resident macrophages of brain. Common mode of action by microglia cells is neuroinflammation and phagocytosis. Moreover, it has been discovered that inflammatory marker levels are increased in AD patients. Recent studies advocate that neuroinflammation plays a major role in AD progression. Microglia have different activation profiles depending on the region of brain and stimuli. In different activation, profile microglia can generate either pro-inflammatory or anti-inflammatory responses. Microglia defend brain cells from pathogens and respond to injuries; also, microglia can lead to neuronal death along the way. In this review, we will bring the different roles played by microglia and microglia-related genes in the progression of AD.

Keywords: Alzheimer's; LYN-kinase; cognitive dysfunction; disease-associated microglia; toll-like receptor-4.

Publication types

  • Review